Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fearfield

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Dermatology|March 9, 2021
Dermatology virtual consultations: are we providing the best care for our patients?N P Patel, L Fearfield
Clinical and Experimental Dermatology|September 25, 2018
Topical dapsone gel is a new treatment option for acne agminataL Ferguson, L Fearfield
Clinical and Experimental Dermatology|February 18, 2018
Nivolumab-induced lichenoid dermatitis occurring in a patient with metastatic melanoma successfully treated with alitretinoinC Edwards, L Fearfield
Clinical and Experimental Dermatology|May 18, 2018
Paraneoplastic pemphigus foliaceus related to underlying breast cancerL Ferguson, L Fearfield
The British Journal of Dermatology|September 20, 2014
Clinical resolution of vemurafenib-induced squamous cell carcinoma with topical 5-fluorouracilR Sinha, J Larkin, L Fearfield
International Journal of Obstetric Anesthesia|July 24, 2007
Neuroaxial blockade and psoriasisM Jackson, J Bird, L Fearfield
Clinical and Experimental Dermatology|June 4, 2014
Radiation-induced morphoea treated with UVA-1 phototherapyD Lim, S Johnston, L Novakovic, et al.
The British Journal of Dermatology|August 6, 2019
Severe vitamin D deficiency associated with BRAF-mutated melanomaL Fearfield, J Nobbs, A Petruckevitch, et al.
The British Journal of Dermatology|June 26, 2015
Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation-positive metastatic melanoma, including recognition and management of rare presentationsR Sinha, J Larkin, M Gore, et al.
Clinical and Experimental Dermatology|April 19, 2021
A blistering dermatosis within depigmented skinA K Uthayakumar, M C Wilmot, P Anketell, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Dermatology|March 9, 2021
Dermatology virtual consultations: are we providing the best care for our patients?N P Patel, L Fearfield
Clinical and Experimental Dermatology|September 25, 2018
Topical dapsone gel is a new treatment option for acne agminataL Ferguson, L Fearfield
Clinical and Experimental Dermatology|February 18, 2018
Nivolumab-induced lichenoid dermatitis occurring in a patient with metastatic melanoma successfully treated with alitretinoinC Edwards, L Fearfield
Clinical and Experimental Dermatology|May 18, 2018
Paraneoplastic pemphigus foliaceus related to underlying breast cancerL Ferguson, L Fearfield
The British Journal of Dermatology|September 20, 2014
Clinical resolution of vemurafenib-induced squamous cell carcinoma with topical 5-fluorouracilR Sinha, J Larkin, L Fearfield
International Journal of Obstetric Anesthesia|July 24, 2007
Neuroaxial blockade and psoriasisM Jackson, J Bird, L Fearfield
Clinical and Experimental Dermatology|June 4, 2014
Radiation-induced morphoea treated with UVA-1 phototherapyD Lim, S Johnston, L Novakovic, et al.
The British Journal of Dermatology|August 6, 2019
Severe vitamin D deficiency associated with BRAF-mutated melanomaL Fearfield, J Nobbs, A Petruckevitch, et al.
The British Journal of Dermatology|June 26, 2015
Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation-positive metastatic melanoma, including recognition and management of rare presentationsR Sinha, J Larkin, M Gore, et al.
Clinical and Experimental Dermatology|April 19, 2021
A blistering dermatosis within depigmented skinA K Uthayakumar, M C Wilmot, P Anketell, et al.
Pageof 3